ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Chicago, IL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Lung Cancer
Non-Small-Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Chicago, IL, USA:

Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced Pancreatic Cancer (LAPIS)

with either gemcitabine plus nab-paclitaxel (G/NP) or FOLFIRINOX in the treatment of participants with locally advanced, unresectable pancreatic...

Active, not recruiting
Pancreatic Cancer Non-resectable
Drug: Pamrevlumab + Gemcitabine + Nab-paclitaxel or Pamrevlumab + FOLFIRINOX
Drug: Placebo + Gemcitabine + Nab-paclitaxel or Placebo + FOLFIRINOX

Phase 3

FibroGen
FibroGen

Elmhurst, Illinois, United States and 89 other locations

Initial study to evaluate local control and the preferred method of attachment of the CivaSheet in the setting of suspected close or positive margins...

Enrolling
Pancreatic Cancer
Device: Directional Brachytherapy Source Implant

Phase 1, Phase 2

CivaTech Oncology

Chicago, Illinois, United States and 4 other locations

A) vs. mFOLFIRINOX plus placebo (Arm B) in 94 subjects with advanced pancreatic cancer, not amenable to curative treatment. Both ar...

Active, not recruiting
Pancreatic Cancer
Drug: Ramucirumab
Drug: mFOLFIRINOX

Phase 2

Walid Shaib, MD

Munster, Indiana, United States and 7 other locations

Subjects will be offered the opportunity to participate in a randomized, controlled, 2-arm, unblinded multicenter trial (RCT). There will be 2 study...

Enrolling
Stage III Pancreatic Cancer
Device: NanoKnife System
Drug: Modified FOLFIRINOX Regimen

Phase 3

AngioDynamics
AngioDynamics

Arlington Heights, Illinois, United States and 5 other locations

A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS muta...

Enrolling
Stage III Non-small Cell Lung Cancer
Stage III Pancreatic Cancer
Drug: BMF-219

Phase 1

Biomea Fusion

Chicago, Illinois, United States and 22 other locations

Study of NGM120 in subjects with advanced solid tumors and and pancreatic cancer (Part 1 and 2) and metastatic castration resistant...

Active, not recruiting
Bladder Cancer
Esophageal Cancer
Biological: NGM120
Other: Placebo

Phase 1, Phase 2

NGM Biopharmaceuticals

Chicago, Illinois, United States and 21 other locations

in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal Adenocarcinoma (PDAC) who have been previously untreat...

Enrolling
Metastatic Cancer
Neoplasms Pancreatic
Drug: avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel

Phase 1, Phase 2

Verastem

Chicago, Illinois, United States and 10 other locations

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal, Pancreatic, or Colorectal Cancer...

Active, not recruiting
Chemotherapy-induced Thrombocytopenia
Other: Placebo
Biological: Romiplostim

Phase 3

Amgen
Amgen

Skokie, Illinois, United States and 116 other locations

compared to just chemotherapy alone in participants with metastatic pancreatic cancer. One group of participants will only receive ...

Enrolling
Metastatic Pancreatic Ductal Adenocarcinoma
Drug: Nab-paclitaxel
Drug: Gemcitabine

Phase 2

Agenus
Agenus

Arlington Heights, Illinois, United States and 35 other locations

treatment combinations in participants with metastatic Pancreatic Ductal Adenocarcinoma (PDAC).Two cohorts will be enrolled in parallel in t...

Active, not recruiting
Pancreatic Adenocarcinoma
Drug: Fluorouracil
Drug: RO6874281

Phase 1, Phase 2

Roche
Roche

Chicago, Illinois, United States and 26 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems